1. Home
  2. PLUR vs BRLT Comparison

PLUR vs BRLT Comparison

Compare PLUR & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • BRLT
  • Stock Information
  • Founded
  • PLUR 2001
  • BRLT 2005
  • Country
  • PLUR Israel
  • BRLT United States
  • Employees
  • PLUR N/A
  • BRLT N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • BRLT Consumer Specialties
  • Sector
  • PLUR Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • PLUR Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • PLUR 37.6M
  • BRLT 36.6M
  • IPO Year
  • PLUR N/A
  • BRLT 2021
  • Fundamental
  • Price
  • PLUR $4.48
  • BRLT $2.35
  • Analyst Decision
  • PLUR Strong Buy
  • BRLT Hold
  • Analyst Count
  • PLUR 1
  • BRLT 2
  • Target Price
  • PLUR $12.00
  • BRLT $1.80
  • AVG Volume (30 Days)
  • PLUR 9.3K
  • BRLT 119.8K
  • Earning Date
  • PLUR 11-11-2025
  • BRLT 11-06-2025
  • Dividend Yield
  • PLUR N/A
  • BRLT N/A
  • EPS Growth
  • PLUR N/A
  • BRLT N/A
  • EPS
  • PLUR N/A
  • BRLT N/A
  • Revenue
  • PLUR $1,336,000.00
  • BRLT $422,218,000.00
  • Revenue This Year
  • PLUR $246.11
  • BRLT $5.45
  • Revenue Next Year
  • PLUR $169.62
  • BRLT $3.28
  • P/E Ratio
  • PLUR N/A
  • BRLT N/A
  • Revenue Growth
  • PLUR 309.82
  • BRLT N/A
  • 52 Week Low
  • PLUR $3.33
  • BRLT $1.25
  • 52 Week High
  • PLUR $7.13
  • BRLT $3.10
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 46.99
  • BRLT 53.89
  • Support Level
  • PLUR $4.08
  • BRLT $1.98
  • Resistance Level
  • PLUR $4.50
  • BRLT $2.10
  • Average True Range (ATR)
  • PLUR 0.22
  • BRLT 0.15
  • MACD
  • PLUR -0.02
  • BRLT 0.01
  • Stochastic Oscillator
  • PLUR 65.05
  • BRLT 67.71

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: